Characterization of Retinal Microvascular and FAZ Changes in Ischemic Stroke and Its Different Types

Sponsor
Peking University Third Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05243849
Collaborator
(none)
100
1
5
20.2

Study Details

Study Description

Brief Summary

The study aimed to access the microvascular changes in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) in patients with ischemic stroke and its different types using optical coherence tomography angiography.

Condition or Disease Intervention/Treatment Phase
  • Device: Optical Coherence Tomography Angiography

Detailed Description

Investigators used OCTA to quantitatively access the retinal microvasculature of SCP and DCP, aiming to detect the geometry changes of retinal microvasculature and FAZ in ischemic stroke patients and its different types.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Characterization of Retinal Microvascular and FAZ Changes in Ischemic Stroke and Its Different Types
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Ischemic Stroke

The diagnosis of ischemic stroke was obtained from previous diagnostic reports or electronic medical records, according to the diagnostic criteria from the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Device: Optical Coherence Tomography Angiography
Optical coherence tomography angiography (OCTA) is a novel non-invasive, non-dye and high-resolution imaging technique, allowing real-time quantitative evaluation of retinal vasculature and the structure of foveal avascular zone (FAZ).

Control

Inclusion criteria for healthy controls were no history of ischemic stroke or other neurological and ocular diseases.

Device: Optical Coherence Tomography Angiography
Optical coherence tomography angiography (OCTA) is a novel non-invasive, non-dye and high-resolution imaging technique, allowing real-time quantitative evaluation of retinal vasculature and the structure of foveal avascular zone (FAZ).

Outcome Measures

Primary Outcome Measures

  1. Vascular Area Density(VAD) [immediately after meeting the inclusion and exclusion criteria]

    The total length in millimeters of perfused retinal microvasculature per unit area in square millimeters in the annular region of analyzed area

  2. Vascular Fractal Dimension(VFD) [immediately after meeting the inclusion and exclusion criteria]

    A well-known parameter which indicates the degree of geometric complexity of vasculature

  3. Vascular Orientation Distribution(VOD) [immediately after meeting the inclusion and exclusion criteria]

    The direction of each vascular pixel to indicate the trend of the blood flow

  4. FAZ Area(FA) [immediately after meeting the inclusion and exclusion criteria]

    The total numbers of pixels in the FAZ region

  5. FAZ Axis Ratio(FAR) [immediately after meeting the inclusion and exclusion criteria]

    The ratio between the major and minor axes of the fitted ellipse from the FAZ boundary. The axis ratio of a perfect circular FAZ is equal to 1

  6. FAZ Circularity(FC) [After meeting the inclusion and exclusion criteria]

    The ratio of the perimeter of the FAZ to the parameter of a circle with equal area, reflecting the degree of roundness of the FAZ

  7. FAZ Roundness(FR) [immediately after meeting the inclusion and exclusion criteria]

    Similar to FC, but is less sensitive to irregular borders along the parameter of FAZ

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Patients who were diagnosed with ischemic stroke by MRI were scheduled for an OCTA examination. The diagnosis of ischemic stroke was obtained from previous diagnostic reports or electronic medical records, according to the diagnostic criteria from the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Exclusion Criteria:
  1. Retinal diseases or diseases affecting vessel structure in fundus photography, including age-related maculopathy; diabetic retinopathy, central serous chorioretinopathy, retinal pigment epithelial detachment and glaucoma); poor cooperation in ophthalmic examinations; high refractive error (>+6.00 D or <-6.00 D Spherical Equivalent); low-quality OCTA images (signal strength index < 6/10). Inclusion criteria for healthy controls were no history of ischemic stroke or other neurological and ocular diseases.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University Third Hospital Beijing China

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

  • Study Director: Hongyu Duan, MD, Peking University Third Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT05243849
Other Study ID Numbers:
  • OCTA
First Posted:
Feb 17, 2022
Last Update Posted:
Feb 17, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Peking University Third Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2022